US Trial Testing Harmony’s Pitolisant for Excessive Sleep Starts Recruiting Patients
A Phase 2 clinical trial testing pitolisant as a treatment for excessive daytime sleepiness (EDS) in Prader-Willi syndrome (PWS) has started recruiting patients at its Texas site and is activating nine other study sites across the U.S. Harmony Biosciences expects the…